510(k) K972986

ACCURUN 140 RUBELLA IGG POSITIVE CONTROL by Boston Biomedica, Inc. — Product Code MJX

K972986 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN 140 RUBELLA IGG POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on October 8, 1997. The device falls under product code MJX (Kit, Serological, Positive Control), a Class I device regulated under 21 CFR 862.1660. Boston Biomedica, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 8, 1997
Date Received
August 11, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Kit, Serological, Positive Control
Device Class
Class I
Regulation Number
862.1660
Review Panel
MI
Submission Type